GERI-KOT- sennosides tablet 
Geri-Care Pharmaceutical Corp

----------

GC 451C 417

Active ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

Warnings

Do not use for more than one week unless directed by a doctor.

Ask a doctor before use if you have
• stomach pain, nausea or vomiting
• noticed a change in bowel habits that lasts over two weeks
Stop use and ask a doctor if you have rectal bleeding

or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor



Other information

Inactive ingredients

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, PEG, talc.

Package Label

1

GERI-KOT 
sennosides tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57896-417
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
TALC (UNII: 7SEV7J4R1U)  
MINERAL OIL (UNII: T5L8T28FGP)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize9mm
FlavorImprint Code 1122
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57896-417-01100 in 1 BOTTLE; Type 0: Not a Combination Product01/01/2024
2NDC:57896-417-101000 in 1 BOTTLE; Type 0: Not a Combination Product01/01/2024
3NDC:57896-417-20200 in 1 BOTTLE; Type 0: Not a Combination Product01/01/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)01/01/2024
Labeler - Geri-Care Pharmaceutical Corp (611196254)
Registrant - Geri-Care Pharmaceutical Corp (611196254)

Revised: 2/2024
Document Id: 105624b2-dd81-8462-e063-6394a90a7e0d
Set id: 10562fb3-f387-ad33-e063-6394a90a14a1
Version: 1
Effective Time: 20240201
 
Geri-Care Pharmaceutical Corp